Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

90
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
90
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

66
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
66
Venous Return01:04

Venous Return

5.4K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated treatment of tannery wastewater by coagulation-flocculation and ultrasound-assisted photo-Fenton-like heterogeneous process using a valorized sludge-based catalyst: optimization of operational performance and toxicity assessment.

Environmental science and pollution research international·2026
Same author

GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes.

Diabetes, obesity & metabolism·2026
Same author

Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis.

Journal of the American Heart Association·2026
Same author

Sotatercept as an Add-On to Background Therapy in Idiopathic Pulmonary Arterial Hypertension: Insights from a Real-World Cohort.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

GLP-1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity-Matched Real-World Analysis.

Diabetes, obesity & metabolism·2026
Same author

Pyruvate Dehydrogenase Complex Deficiency: A Review of Treatments and Case Series.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Aug 5, 2025

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.5K

Vascular Function in Continuous Flow LVADs: Implications for Clinical Practice.

Fouad Khalil1, Rabea Asleh2,3, Radha Kanneganti Perue4

  • 1Department of Internal Medicine, University of South Dakota, Sioux Falls, SD 57105, USA.

Biomedicines
|March 29, 2023
PubMed
Summary
This summary is machine-generated.

Continuous flow (CF) left ventricular assist devices (LVADs) improve advanced heart failure care but cause significant vascular issues. Newer CF-LVADs reduce stroke but not gastrointestinal bleeding, necessitating further research.

Keywords:
continuous flow left ventricular assist devicecoronary artery diseasegastrointestinal bleedingperipheral artery diseasepulmonary hypertensionstroke

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
06:27

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring

Published on: May 2, 2025

238

Related Experiment Videos

Last Updated: Aug 5, 2025

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.5K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
06:27

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring

Published on: May 2, 2025

238

Area of Science:

  • Cardiovascular Medicine
  • Medical Devices
  • Vascular Biology

Background:

  • Left ventricular assist devices (LVADs) are crucial for advanced heart failure management, serving as destination therapy or bridge-to-transplant.
  • Continuous flow (CF) LVADs represent a significant advancement in treating advanced heart failure.
  • However, the use of CF-LVADs is associated with considerable vascular pathology and complications.

Purpose of the Study:

  • To comprehensively review the impact of continuous flow left ventricular assist devices (CF-LVADs) on the vasculature.
  • To explore the pathophysiology, clinical implications, and future research directions concerning CF-LVAD-associated vascular complications.

Main Methods:

  • Literature review synthesizing current research on CF-LVADs and vascular complications.
  • Analysis of pathophysiology, clinical outcomes, and emerging trends in the field.

Main Results:

  • While newer generations of CF-LVADs have decreased the incidence of certain vascular complications like stroke.
  • Significant challenges remain, with no substantial improvement observed in the rates of other complications, such as gastrointestinal bleeding.
  • The review highlights a complex relationship between CF-LVAD support and vascular health.

Conclusions:

  • CF-LVADs have transformed heart failure treatment but necessitate careful management of vascular complications.
  • Further research is critical to mitigate risks like gastrointestinal bleeding and improve long-term outcomes.
  • Understanding and addressing LVAD-induced vascular pathology is essential for optimizing patient care.